A Y Foo

1.1k total citations
29 papers, 858 citations indexed

About

A Y Foo is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, A Y Foo has authored 29 papers receiving a total of 858 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Molecular Biology and 8 papers in Surgery. Recurrent topics in A Y Foo's work include Alkaline Phosphatase Research Studies (12 papers), Pancreatitis Pathology and Treatment (5 papers) and Liver Disease Diagnosis and Treatment (4 papers). A Y Foo is often cited by papers focused on Alkaline Phosphatase Research Studies (12 papers), Pancreatitis Pathology and Treatment (5 papers) and Liver Disease Diagnosis and Treatment (4 papers). A Y Foo collaborates with scholars based in United Kingdom, Denmark and Australia. A Y Foo's co-authors include S B Rosalki, Sheila Sherlock, Owen Epstein, R Chapman, Gerond Lake‐Bakaar, Sidney B. Rosalki, Heinz Bodenmüller, D. Neumeier, W. Prellwitz and Angelo Burlina and has published in prestigious journals such as Gastroenterology, Gut and International Journal of Molecular Sciences.

In The Last Decade

A Y Foo

29 papers receiving 799 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Y Foo United Kingdom 14 298 222 189 157 148 29 858
G Wolf Germany 14 153 0.5× 129 0.6× 119 0.6× 32 0.2× 35 0.2× 51 703
Kimitaka Takitani Japan 14 79 0.3× 62 0.3× 315 1.7× 23 0.1× 42 0.3× 54 657
Mohsen Elshahaly Egypt 6 26 0.1× 121 0.5× 213 1.1× 175 1.1× 180 1.2× 13 699
Howard Sussman United States 10 63 0.2× 48 0.2× 234 1.2× 57 0.4× 20 0.1× 10 679
Sergio Sánchez‐Enríquez Mexico 14 83 0.3× 80 0.4× 109 0.6× 45 0.3× 52 0.4× 36 592
Gabriela Angélica Martínez‐Nava Mexico 17 43 0.1× 104 0.5× 353 1.9× 254 1.6× 25 0.2× 54 977
Salih Deveci Türkiye 16 121 0.4× 366 1.6× 92 0.5× 56 0.4× 5 0.0× 45 893
Ahmed Bilal Waqar Japan 18 117 0.4× 144 0.6× 181 1.0× 29 0.2× 13 0.1× 51 843

Countries citing papers authored by A Y Foo

Since Specialization
Citations

This map shows the geographic impact of A Y Foo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Y Foo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Y Foo more than expected).

Fields of papers citing papers by A Y Foo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Y Foo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Y Foo. The network helps show where A Y Foo may publish in the future.

Co-authorship network of co-authors of A Y Foo

This figure shows the co-authorship network connecting the top 25 collaborators of A Y Foo. A scholar is included among the top collaborators of A Y Foo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Y Foo. A Y Foo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schwarcz, Robert, A Y Foo, Korrapati V. Sathyasaikumar, & Francesca M. Notarangelo. (2024). The Probiotic Lactobacillus reuteri Preferentially Synthesizes Kynurenic Acid from Kynurenine. International Journal of Molecular Sciences. 25(7). 3679–3679. 12 indexed citations
2.
Foo, A Y, et al.. (2002). Confirming congenital hypothyroidism identified from neonatal screening.. PubMed. 71(1). 38–41. 2 indexed citations
3.
Foo, A Y, et al.. (1998). Amylase measurement with 2-chloro-4-nitrophenyl maltotrioside as substrate. Clinica Chimica Acta. 272(2). 137–147. 50 indexed citations
4.
Cuckow, P., et al.. (1997). Familial hyperamylasaemia.. Gut. 40(5). 689–690. 6 indexed citations
5.
Foo, A Y. (1995). Amylase Measurement—Which Method?. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 32(3). 239–243. 10 indexed citations
6.
Rosalki, S B, A Y Foo, Angelo Burlina, et al.. (1993). Multicenter evaluation of Iso-ALP test kit for measurement of bone alkaline phosphatase activity in serum and plasma. Clinical Chemistry. 39(4). 648–652. 101 indexed citations
7.
Rosalki, S B, A Y Foo, & James Dooley. (1993). Benign familial hyperphosphatasaemia as a cause of unexplained increase in plasma alkaline phosphatase activity.. Journal of Clinical Pathology. 46(8). 738–741. 9 indexed citations
8.
Hørder, Mogens, Poul J. Jørgensen, J C Hafkenscheid, et al.. (1991). Creatine kinase determination: a European evaluation of the creatine kinase determination in serum, plasma and whole blood with the Reflotron system.. PubMed. 29(10). 691–6. 32 indexed citations
9.
Rosalki, Sidney B. & A Y Foo. (1989). Lectin affinity electrophoresis of alkaline phosphatase for the differentiation of bone and hepatobiliary disease. Electrophoresis. 10(8-9). 604–611. 19 indexed citations
10.
Rosalki, S B, et al.. (1989). Alkaline phosphatase of possible renal origin identified in plasma after colchicine overdose.. Clinical Chemistry. 35(4). 702–703. 3 indexed citations
11.
Stein, Philip, S B Rosalki, A Y Foo, & M. Hjelm. (1987). Transient hyperphosphatasemia of infancy and early childhood: clinical and biochemical features of 21 cases and literature review.. Clinical Chemistry. 33(2). 313–318. 44 indexed citations
12.
Collins, Dawn R., et al.. (1987). Plasma intestinal alkaline phosphatase and intermediate molecular mass gamma glutamyltransferase activities in the differential diagnosis of jaundice.. Journal of Clinical Pathology. 40(10). 1252–1255. 1 indexed citations
14.
Rosalki, S B & A Y Foo. (1983). Reaction-rate method for determining amylase and isoamylase.. Clinical Chemistry. 29(3). 586–587. 2 indexed citations
15.
Foo, A Y, et al.. (1981). Comparison of Procedures for the Measurement of the Anodal Isoenzymes of Lactate Dehydrogenase in Serum. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 18(4). 232–235. 3 indexed citations
16.
Lester, Eva P., R.K. Skinner, A Y Foo, & B. Lund. (1980). Serum 25-hydroxyvitamin D levels and vitamin D intake in healthy young adults in Britain and Denmark. Scandinavian Journal of Clinical and Laboratory Investigation. 40(2). 145–150. 12 indexed citations
17.
Day, R. C., D. S. Harry, James S. Owen, A Y Foo, & Neil McIntyre. (1979). Lecithin—Cholesterol Acyltransferase and the Lipoprotein Abnormalities of Parenchymal Liver Disease. Clinical Science. 56(6). 575–583. 32 indexed citations
18.
Harry, D. S., et al.. (1978). Plasma Lecithin:Cholesterol Acyltransferase Activity and the Lipoprotein Abnormalities of Liver Disease. Scandinavian Journal of Clinical and Laboratory Investigation. 38(sup150). 223–227. 14 indexed citations
19.
Cramp, D. G., et al.. (1977). Metabolic response to intravenous salbutamol therapy in acute asthma.. Thorax. 32(2). 182–184. 14 indexed citations
20.
Trafford, D.J.H., et al.. (1976). Hydroxyapatite — a reagent for the separation of free and antibody-bound steroid during radioimmunoassay. Steroids. 27(3). 405–422. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026